Article
An Overview of Targeted Therapies in Acute Myeloid Leukemia
26 May 2023
Abstract excerpt
Acute myeloid leukemia (AML) is the most aggressive adult leukemia, characterized by clonal differentiation arrest of progenitor or precursor hematopoietic cells. Intense preclinical and clinical research has led to regulatory approval of several targeted therapeutics, administered either as single agents or as combination therapies. However, the majority of patients still face a poor prognosis and disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
